Dr Ildikó Varga > Nagy és Trócsányi Ügyvédi Iroda > Budapest, Hungary > Lawyer Profile

Nagy és Trócsányi Ügyvédi Iroda
UGOCSA U 4/B
1126 BUDAPEST
Hungary
Ildikó Varga photo

Work Department

Corporate transactions group.

Position

Executive Partner. Head of the corporate transactions group with significant experience and practice in M&A, structuring foreign direct investments and transnational transactions.

Career

Admitted in New York and in Hungary; Nagy és Trócsányi, Budapest Partner, 1993 – to date, Executive Partner, 1996 – to date; Nagy és Trócsányi LLP, New York, Resident Partner, 1993 – 1994; József Attila Tudományegyetem, Faculty of Law, Szeged Associate Professor of Law, 1989 – 1992; Arent Fox Kintner Plotkin & Kahn, Budapest Office, Attorney at Law, 1991 – 1993; White & Case, New York, Foreign Attorney, 1990 – 1991; Arent Fox Kintner Plotkin & Kahn, Washington D.C., Summer Associate, 1991.

Languages

Hungarian, English.

Education

New York University, New York Graduate School of Arts and Sciences (joint program with NYU Law School) General Studies in Law and Philosophy, 1989 – 1990 Honors: Soros Scholarship; Université de Strasbourg, Faculté Internationale de Droit Comparé, Strasbourg Studies in comparative law, 1987; Eötvös Loránd Tudományegyetem, Faculty of Law Budapest General ,Legal Studies, 1982 – 1988 Degree: Doctor of Law; Eötvös Loránd Tudományegyetem, Faculty of Arts; Budapest Ph.D. in Philosophy and Jurisprudence, 1984; Eötvös Loránd Tudományegyetem, Faculty of Arts, Budapest Studies in English Linguistics and Literature, 1975 – 1980, Degree: M.A.

Lawyer Rankings

Hungary > Commercial, corporate and M&A

Nagy és Trócsányi Ügyvédi Iroda provides the full spectrum of commercial, corporate and M&A advice, supporting its diverse clientele from due diligence and structuring to closing of transactions. Practice head Ildikó Varga is experienced in cross-border transactions and regularly advises multinational companies on their inbound investments or acquisitions in Hungary. Balázs Karsai advises commercial banks, as well as agricultural and pharmaceutical companies.